MARKET

BVXV

BVXV

BiondVax
NASDAQ

Real-time Quotes | Nasdaq Last Sale

5.49
-0.17
-3.06%
Pre Market: 5.49 0 0.06% 08:00 10/16 EDT
OPEN
5.40
PREV CLOSE
5.66
HIGH
5.68
LOW
5.34
VOLUME
1
TURNOVER
--
52 WEEK HIGH
7.26
52 WEEK LOW
3.510
MARKET CAP
6.93M
P/E (TTM)
-5.9457
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of BVXV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

BVXV News

  • BiondVax Receives 4M From the European Investment Bank (EIB) in Support of Ongoing Universal Influenza Vaccine Pivotal Phase 3 Trial
  • PR Newswire.10/07 14:15
  • BiondVax Welcomes New Chairman of the Board and Announces Second Quarter 2019 Financial Results
  • PR Newswire.08/28 12:45
  • BVXV: Raises $20 Million; Phase 3 Trial Fully Funded
  • Zacks Small Cap Research.08/01 15:00
  • BiondVax Announces Rights Offering Fully Subscribed at US$20 Million
  • PR Newswire.07/16 12:30

More

Industry

Precious Metals & Minerals
-2.94%
Metals & Mining
-0.63%

Hot Stocks

Name
Price
%Change

About BVXV

Minco Capital Corp, formerly Minco Gold Corporation, is a Canada-based investment company. The Company’s investment objective is to generate income and achieve long-term capital appreciation by investing in public and private companies and assets. The Company invests in publicly traded and privately held corporations, as well as taking indirect and direct ownership stakes in resource projects.
More

Webull offers Minco Capital Corp (BVXV) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.